Healthcare -
Biotechnology - NASDAQ - US
$ 0.2069
-3.32 %
$ 13.5 M
Market Cap
-0.14
P/E
LYRA - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity LYRA - Lyra Therapeutics, Inc.
143 M
LAST VALUE
61.21%
2 YEAR CAGR
41.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR